Insmed Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.8M | $0 | $0 | $0 | — | $11.5M | $0 | $4.4M |
| Cost of Revenue | $2.4M | $0 | $0 | — | — | — | — | — |
| Gross Profit | $7.4M | $0 | $0 | — | — | — | — | — |
| Gross Margin | 75.4% | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $145.3M | $109.7M | $122.7M | $74.3M | $56.3M | $44.3M | $29.8M | $28.6M |
| SG&A Expense | $168.2M | $79.2M | $50.7M | $43.2M | $31.1M | $22.2M | $12.7M | $11.5M |
| Operating Income | $-307.3M | $-188.9M | $-173.4M | $-117.5M | $-87.4M | $-55.0M | $-42.4M | $-61.7M |
| Operating Margin | -3,124.9% | — | — | — | — | -478.4% | — | -1,397.3% |
| Interest Expense | $25.5M | $5.9M | $3.5M | $2.9M | $2.4M | $2.4M | $763.0K | $10.0K |
| Pretax Income | $-324.1M | $-192.9M | $-176.2M | $-120.2M | $-89.6M | $-57.3M | $-41.4M | $-59.7M |
| Income Tax Expense | $201.0K | $-272.0K | $98.0K | $-2.0M | $-10.4M | $-1.2M | $0 | $0 |
| Net Income | $-324.3M | $-192.6M | $-176.3M | $-118.2M | $-79.2M | $-56.1M | $-41.4M | $-59.7M |
| Net Margin | -3,297.2% | — | — | — | — | -487.6% | — | -1,350.8% |
| EPS (Basic) | $-4.22 | $-2.89 | $-2.85 | $-2.02 | $-1.84 | $-1.60 | $-1.56 | $-2.95 |
| EPS (Diluted) | $-4.22 | $-2.89 | $-2.85 | $-2.02 | $-1.84 | $-1.60 | $-1.56 | $-2.95 |
| Shares Outstanding (Basic) | 76.9M | 66.6M | 61.9M | 58.6M | 43.1M | 35.0M | 26.5M | 23.3M |
| Shares Outstanding (Diluted) | 76.9M | 66.6M | 61.9M | 58.6M | 43.1M | 35.0M | 26.5M | 23.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |